Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery.
Primary Purpose
Retinal Detachment
Status
Unknown status
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
Vitrectomy and tamponade
Sponsored by
About this trial
This is an interventional treatment trial for Retinal Detachment focused on measuring Retinal Detachment, Double Tamponade, Perfluorocarbon liquids, Vitrectomy
Eligibility Criteria
Inclusion Criteria:
Adults aged 18 or over with firstly diagnosed rhegmatogenous total retinal detachment:
- with retinal breaks located both in upper and lower retina; OR
- with PVR which was impossible to remove completely during the surgery.
Exclusion Criteria:
- severe concomitant eye pathologies (glaucoma, diabetic retinopathy, macular hole, traumas); OR
- eye length more than 27mm.
Sites / Locations
- SN Fyodorov "Eye Microsurgery" State InstitutionRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Double tamponade
Silicone oil tamponade
Arm Description
Vitrectomy and tamponade: subtotal vitrectomy, epiretinal membrane removal, perfluorodecalin tamponade, retinal photocoagulation. After that the surgeon replaces ½ of perfluorodecalin volume by silicone oil.
Vitrectomy and tamponade: subtotal vitrectomy, epiretinal membrane removal, perfluorodecalin tamponade, retinal photocoagulation and perfluorodecalin-silicone oil exchange.
Outcomes
Primary Outcome Measures
Retinal reattachment rate
Secondary Outcome Measures
Percentage of patients with best corrected visual acuity >/= 20.200
Full Information
NCT ID
NCT01959568
First Posted
September 29, 2013
Last Updated
May 27, 2014
Sponsor
The S.N. Fyodorov Eye Microsurgery State Institution
1. Study Identification
Unique Protocol Identification Number
NCT01959568
Brief Title
Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery.
Official Title
Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery: Randomised Clinical Trial of Safety
Study Type
Interventional
2. Study Status
Record Verification Date
May 2014
Overall Recruitment Status
Unknown status
Study Start Date
March 2010 (undefined)
Primary Completion Date
September 2017 (Anticipated)
Study Completion Date
June 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The S.N. Fyodorov Eye Microsurgery State Institution
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Purpose: to assess the efficacy and safety of double tamponade versus silicone oil tamponade.
Design: parallel-group study with balanced [1:1] stratified block randomization. Eligible participants are all adults aged 18 or over with first diagnosed rhegmatogenous total retinal detachment with retinal breaks located both in upper and lower retina. Also investigators include those patients with total retinal detachment with proliferative vitreoretinopathy (PVR) in which it is impossible to remove epiretinal membranes completely during the surgery (with arbitrary retinal breaks localization). Exclusion criteria are severe concomitant eye pathologies (glaucoma, diabetic retinopathy, macular hole, traumas etc) and eye length more than 27mm.
Patients are randomized in two groups (test group and control group).
In the test group patients undergo subtotal vitrectomy, epiretinal membrane removal, perfluorodecalin (PFD) tamponade, retinal photocoagulation. After that the surgeon replaces ½ of PFD volume by "conventional" SO (with density less than one of water). The result is vitreous cavity (VC) filled in a half with PFD and in another half - with SO. In the control group patients undergo subtotal vitrectomy, epiretinal membrane removal, PFD tamponade, retinal photocoagulation and PFD-SO exchange, so the result is VC filled with "conventional" or heavy SO, depending on predominant retinal breaks location. 30 days after the surgery in both groups tamponing agents are removed from VC and VC is filled with sulfur hexafluoride gas (SF6) which dissolves during 1 month. Follow-up is at least 12 months.
Along with standard examinations, after SF6 gas dissolution investigators perform spectral optical coherence tomography (OCT) and microperimetry. With OCT investigators measure thickness of retinal inner and outer nuclear layers. With microperimetry investigators determine light sensitivity in 12° and 4° zones from the fixation point.
Outcome measures: reattachment rate, best corrected visual acuity (BCVA), intraocular pressure (IOP), thicknesses of inner and outer nuclear layers according to the OCT, light sensitivity according to microperimetry, the rate of cataract formation in phakic eyes and the rate of tamponing agents emulsification.
For final analysis each group will include 145 participants.
OCT, microperimetry data and visual acuity will be compared between the groups using Student's t-test; proportions will be compared using exact Fisher's test.
Detailed Description
The investigators include in the study all successive patients operated by the same surgeon. The study takes place in the S.N. Fyodorov "Eye Microsurgery" Federal State Institution located in Moscow, Russian Federation.
Patients are randomized in two groups with stratified block randomization. Strata were defined by combination of two binary prognostic factors: duration of retinal detachment (less than 3 months and ≥ 3 months) and PVR (present/absent).
Early interim analysis will be performed in order to reveal possible adverse effect of long-term PFD tamponade. For interim report success will mean the rate of post-surgical BCVA >/= 20.200. Groups sizes for interim analysis will be 35 patients in each group. For interim analysis the investigators choose group sizes able to reveal 30% absolute difference in functional success rate with one-sided test (to detect possible toxicity of double tamponade for the retina) having power of 0.8 and significance level of p=0.05. In the final analysis success will mean retinal reattachment.
For final analysis each group will include 145 participants, so that the investigators are able to detect 15% difference in reattachment rate with power of 0.8 and significance level of p=0.05. Group sizes were computed with exact Fisher's test function in G*Power 3.1.7 software (Erdfelder, Faul, & Buchner).
OCT is performed with Cirrus HD-OCT system (Zeiss Meditec Inc). Microperimetry is performed with MP-1 microperimeter (Nidek). All the examinations are assessed by one ophthalmologist.
The allocation concealment is implemented with the help of a third party, who stores the randomization list and prepares envelopes containing directions what method of tamponade to employ in each particular patient. Patients are blind to the method of tamponade.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Retinal Detachment
Keywords
Retinal Detachment, Double Tamponade, Perfluorocarbon liquids, Vitrectomy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
290 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Double tamponade
Arm Type
Experimental
Arm Description
Vitrectomy and tamponade: subtotal vitrectomy, epiretinal membrane removal, perfluorodecalin tamponade, retinal photocoagulation. After that the surgeon replaces ½ of perfluorodecalin volume by silicone oil.
Arm Title
Silicone oil tamponade
Arm Type
Active Comparator
Arm Description
Vitrectomy and tamponade: subtotal vitrectomy, epiretinal membrane removal, perfluorodecalin tamponade, retinal photocoagulation and perfluorodecalin-silicone oil exchange.
Intervention Type
Procedure
Intervention Name(s)
Vitrectomy and tamponade
Other Intervention Name(s)
Perfluorodecalin Dk-Line (Bausch&Lomb), Silicone oil Oxane 1300 (Bausch&Lomb), Silicone oil Oxane HD (Bausch&Lomb)
Intervention Description
In the double tamponade arm the result of surgery is vitreous cavity filled in a half with perfluorodecalin and in another half - with silicone oil.
In the silicone oil tamponade arm the result of surgery is vitreous cavity filled with "conventional" or heavy silicone oil, depending on predominant retinal breaks location.
Primary Outcome Measure Information:
Title
Retinal reattachment rate
Time Frame
in 1 month after tamponade removal.
Secondary Outcome Measure Information:
Title
Percentage of patients with best corrected visual acuity >/= 20.200
Time Frame
in 1 month after tamponade removal
Other Pre-specified Outcome Measures:
Title
Percentage of patients with intraocular pressure >/= 25 mm Hg
Time Frame
in 1 month after tamponade removal.
Title
Percentage of phakic eyes in which cataract occurred during tamponade
Time Frame
During tamponade removal.
Title
Percentage of eyes with tamponing substances emulsification
Time Frame
During tamponade removal.
Title
Thickness of retinal inner and outer nuclear layers
Description
Measured with Optical Coherence Tomography
Time Frame
in 1 month after tamponade removal
Title
Retinal light sensitivity
Description
Measured with microperimetry
Time Frame
in 1 month after tamponade removal
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults aged 18 or over with firstly diagnosed rhegmatogenous total retinal detachment:
with retinal breaks located both in upper and lower retina; OR
with PVR which was impossible to remove completely during the surgery.
Exclusion Criteria:
severe concomitant eye pathologies (glaucoma, diabetic retinopathy, macular hole, traumas); OR
eye length more than 27mm.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Pavel V Lyskin, PhD
Phone
+79165558019
Email
plyskin@yahoo.com
First Name & Middle Initial & Last Name or Official Title & Degree
Elena G Kazimirova, MD
Phone
+79165898410
Email
lena.kazimirova@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pavel V Lyskin, PhD
Organizational Affiliation
SN Fyodorov "Eye Microsurgery" State Institution
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Valery D Zakharov, Professor
Organizational Affiliation
SN Fyodorov "Eye Microsurgery" State Institution
Official's Role
Study Director
Facility Information:
Facility Name
SN Fyodorov "Eye Microsurgery" State Institution
City
Moscow
ZIP/Postal Code
127486
Country
Russian Federation
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pavel V Lyskin, PhD
Phone
+79165558019
Email
plyskin@yahoo.com
First Name & Middle Initial & Last Name & Degree
Elena G Kazimirova, MD
Phone
+79165898410
Email
lena.kazimirova@gmail.com
First Name & Middle Initial & Last Name & Degree
Pavel V Lyskin, PhD
First Name & Middle Initial & Last Name & Degree
Elena G Kazimirova, MD
12. IPD Sharing Statement
Citations:
PubMed Identifier
32408387
Citation
Schwartz SG, Flynn HW Jr, Wang X, Kuriyan AE, Abariga SA, Lee WH. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy. Cochrane Database Syst Rev. 2020 May 13;5(5):CD006126. doi: 10.1002/14651858.CD006126.pub4.
Results Reference
derived
Learn more about this trial
Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery.
We'll reach out to this number within 24 hrs